US 12,115,187 B1
Ready-to-use sodium phosphates injection
Niravbhai Jayantibhai Patel, Sacramento, CA (US); Robert Miller, Sacramento, CA (US); Maheshkumar Kalubhai Bhalaria, Sacramento, CA (US); Rucha Abhijit Kelekar, Sacramento, CA (US); Brijeshkumar B Pandya, Sacramento, CA (US); Sunil Dnyanu Khandekar, Sacramento, CA (US); Sudhir Shantarum Jagdale, Sacramento, CA (US); Dasaradhi Lakkaraju, Sacramento, CA (US); and Jay Shukla, Sacramento, CA (US)
Assigned to Nivagen Pharmaceuticals, Inc., Sacramento, CA (US)
Filed by Nivagen Pharmaceuticals, Inc., Sacramento, CA (US)
Filed on May 17, 2024, as Appl. No. 18/667,826.
Int. Cl. A61K 33/42 (2006.01); A61J 1/10 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01)
CPC A61K 33/42 (2013.01) [A61J 1/10 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01)] 15 Claims
 
1. A sterile ready-to-use aqueous sodium phosphates solution, comprising sodium phosphates, wherein the solution comprises between 1.5 mmol/100 mL and 15 mmol/100 mL phosphorus and equal or less than 25 mcg/L aluminum, and wherein the solution has a pH of between 6.2 and 6.8.